Pharma seeks to offload old drugs

Share this article:

The industry merry-go-round of sales and swaps continues to spin. The Wall Street Journal reports that Sanofi, Merck and GlaxoSmithKline are independently exploring ways to offload their portfolios of older drugs. Insiders tell the Journal that Merck has been chatting up possible buyers of a series of drugs for about $15 billion, and that Sanofi is thinking of a joint venture to house some of its mature products.

GlaxoSmithKline, which recently participated in an asset swap with Novartis is also said to be contemplating divestment of older products.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

This compelling e-book shares a wealth of insights designed to help members of sales forces connect with elusive HCPs. An expanded version has also been created that includes video interviews and other multimedia content. Click here for access.